Clinical Study

Kidney Dosimetry in 177Lu and 90Y Peptide Receptor Radionuclide Therapy: Influence of Image Timing, Time-Activity Integration Method, and Risk Factors

Table 2

The mean fraction of time-integrated activity per unit activity situated after the last experimental datum is reported for the methods TRph, TRexp, BI, MN, MNfix, VIS, FT.

TRphTRexpBIMNMNfixFTVIS

177Lu TOC0.730.290.400.380.450.430.38
177Lu TATE0.730.340.420.430.350.380.41
90Y TOC0.560.280.260.240.390.330.25
90Y TATE0.570.320.270.280.280.280.26